XPANDOMER
LIVE

Serial Number

97900361

Owner

ROCHE MOLECULAR SYSTEMS, INC.

Attorney

Mona Gupta

Filing Date

Apr 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

XPANDOMER Trademark

Serial Number: 97900361

XPANDOMER is a trademark filed by ROCHE MOLECULAR SYSTEMS, INC. on April 21, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

ROCHE MOLECULAR SYSTEMS, INC. (196 trademarks)

Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

April 21, 2023

Registration Date

Not Registered

Published for Opposition

April 23, 2024

Goods & Services

In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits comprised of reagents for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with DNA sequencing and genetic analysis

Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for DNA sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing DNA sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes

In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing DNA, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 16, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 19, 2025 EX2G
SOU EXTENSION 2 FILED
May 19, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 14, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 14, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 18, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 12, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2023 CNSA
ASSIGNED TO EXAMINER
Nov 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2023 NWOS
NEW APPLICATION ENTERED
Apr 25, 2023 NWAP